Exploring paraptosis as a therapeutic approach in cancer treatment

Ling-Chu Chang1,2,3, Shih-Kai Chiang4, Shuen-Ei Chen4,5,6,7

  • 1Center for Molecular Medicine, China Medical University Hospital, Taichung, 406040, Taiwan. 027602@tool.caaumed.org.tw.

PubMed

Insights

Paraptosis, a distinct cell death pathway, involves cytoplasmic vacuolization and lacks caspase activation. Targeting paraptosis offers promising therapeutic strategies for cancer treatment.

Area of Science:

  • Cell Biology
  • Molecular Medicine
  • Oncology

Background:

  • Cell death pathways are crucial in disease development.
  • Paraptosis is a unique programmed cell death characterized by cytoplasmic vacuolization and organelle swelling, distinct from apoptosis and necrosis.
  • It does not involve caspase activation.

Purpose of the Study:

  • To review recent findings on paraptosis.
  • To delineate the signaling pathways involved in paraptosis.
  • To discuss the therapeutic potential of targeting paraptosis in cancer treatment.

Main Methods:

  • Literature review of recent studies on paraptosis.
  • Analysis of signaling pathways regulating paraptosis.
  • Evaluation of therapeutic strategies targeting paraptosis.

Main Results:

  • Paraptosis is induced by various agents including natural products, synthetic compounds, and nanomedicines.
  • Key features include cytoplasmic vacuolization and swelling of endoplasmic reticulum and mitochondria.
  • Absence of caspase activation distinguishes it from apoptosis.

Conclusions:

  • Paraptosis represents a significant area of research in cell death.
  • Understanding paraptosis mechanisms can lead to novel cancer therapies.
  • Targeting paraptosis presents a promising avenue for oncological treatment strategies.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
484
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.6K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K